Putzhammer, Albert and Schoeler, Anja and Rohrmeier, Thomas and Sand, Philipp and Hajak, Goeran and Eichhammer, Peter (2005) Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment. PSYCHOPHARMACOLOGY, 178 (2-3). pp. 303-308. ISSN 0033-3158, 1432-2072
Full text not available from this repository. (Request a copy)Abstract
Rationale: Serotonergic mechanisms are thought to play an important role in the regulation of mood, motor activity and sleep patterns. Serotonin reuptake is controlled by the serotonin transporter (5-HTT) and by a common functional insertion/deletion polymorphism in the corresponding gene's promoter region (5-HTTLPR). Homozygosity for the long variant may confer a favourable response to treatment with serotonin reuptake inhibitors (SSRIs), and to sleep deprivation. Objectives: The study assessed the role of the 5-HTTLPR genotype in determining motor side effects of antidepressant medication. Methods: Motor activity patterns of 62 patients with major depression who were being treated with either SSRIs or tricyclic antidepressants (TCAs) were monitored over a 24-h period using a wristactograph. Additionally, motor activity was rated in a semi-structured interview using the motor agitation and retardation scale (MARS). Results: Night-time motor activity was significantly increased in homozygous carriers of the long 5-HTTLPR allele (LL-genotype) who were being treated with SSRIs in comparison to short allele carriers (LS-genotype and SS-genotype), regardless of the type of antidepressant treatment (P < 0.001). It was also significantly increased in comparison to patients with the LL-genotype who were being treated with TCAs (P < 0.01). Differences in actographic motor activity were most prominent between 11 p. m. and 4 a. m. Clinical ratings of motor activity also showed a trend toward higher agitation scores in patients with the LL-genotype who received SSRI treatment. Conclusions: Homozygosity for the long variant of the 5-HTTLPR may cause a predisposition to increased night-time motor activity in conjunction with SSRI treatment.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSIVE DISORDER; ALLELIC VARIATION; FUNCTIONAL POLYMORPHISM; REUPTAKE INHIBITORS; SLEEP-DEPRIVATION; DOUBLE-BLIND; PAROXETINE; ASSOCIATION; PROMOTER; serotonin transporter gene; serotonin reuptake inhibitor; tricyclic antidepressant; motor side effects; actography |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Psychiatrie und Psychotherapie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 25 May 2021 13:21 |
| Last Modified: | 25 May 2021 13:21 |
| URI: | https://pred.uni-regensburg.de/id/eprint/36464 |
Actions (login required)
 |
View Item |
